Identification of metabolic correlates of mild cognitive impairment in Parkinson's disease using magnetic resonance spectroscopic imaging and machine learning
- PMID: 35867235
- DOI: 10.1007/s10334-022-01030-6
Identification of metabolic correlates of mild cognitive impairment in Parkinson's disease using magnetic resonance spectroscopic imaging and machine learning
Abstract
Objective: To investigate metabolic changes of mild cognitive impairment in Parkinson's disease (PD-MCI) using proton magnetic resonance spectroscopic imaging (1H-MRSI).
Methods: Sixteen healthy controls (HC), 26 cognitively normal Parkinson's disease (PD-CN) patients, and 34 PD-MCI patients were scanned in this prospective study. Neuropsychological tests were performed, and three-dimensional 1H-MRSI was obtained at 3 T. Metabolic parameters and neuropsychological test scores were compared between PD-MCI, PD-CN, and HC. The correlations between neuropsychological test scores and metabolic intensities were also assessed. Supervised machine learning algorithms were applied to classify HC, PD-CN, and PD-MCI groups based on metabolite levels.
Results: PD-MCI had a lower corrected total N-acetylaspartate over total creatine ratio (tNAA/tCr) in the right precentral gyrus, corresponding to the sensorimotor network (p = 0.01), and a lower tNAA over myoinositol ratio (tNAA/mI) at a part of the default mode network, corresponding to the retrosplenial cortex (p = 0.04) than PD-CN. The HC and PD-MCI patients were classified with an accuracy of 86.4% (sensitivity = 72.7% and specificity = 81.8%) using bagged trees.
Conclusion: 1H-MRSI revealed metabolic changes in the default mode, ventral attention/salience, and sensorimotor networks of PD-MCI patients, which could be summarized mainly as 'posterior cortical metabolic changes' related with cognitive dysfunction.
Keywords: Cognitive dysfunction; Machine learning; Magnetic resonance spectroscopy; Parkinson’s disease.
© 2022. The Author(s), under exclusive licence to European Society for Magnetic Resonance in Medicine and Biology (ESMRMB).
Similar articles
-
Machine learning for the detection and diagnosis of cognitive impairment in Parkinson's Disease: A systematic review.PLoS One. 2024 May 16;19(5):e0303644. doi: 10.1371/journal.pone.0303644. eCollection 2024. PLoS One. 2024. PMID: 38753740 Free PMC article.
-
Frontal lobe metabolic alterations characterizing Parkinson's disease cognitive impairment.Neurol Sci. 2021 Mar;42(3):1053-1064. doi: 10.1007/s10072-020-04626-9. Epub 2020 Jul 29. Neurol Sci. 2021. PMID: 32729012
-
Impairment of the visuospatial working memory in the patients with Parkinson's Disease: an fMRI study.BMC Neurol. 2021 Sep 3;21(1):335. doi: 10.1186/s12883-021-02366-7. BMC Neurol. 2021. PMID: 34479502 Free PMC article.
-
The cerebral blood flow deficits in Parkinson's disease with mild cognitive impairment using arterial spin labeling MRI.J Neural Transm (Vienna). 2020 Sep;127(9):1285-1294. doi: 10.1007/s00702-020-02227-6. Epub 2020 Jul 6. J Neural Transm (Vienna). 2020. PMID: 32632889
-
Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression.Neuropsychol Rev. 2022 Mar;32(1):149-160. doi: 10.1007/s11065-021-09502-7. Epub 2021 Apr 16. Neuropsychol Rev. 2022. PMID: 33860906 Review.
Cited by
-
Early diagnostic value of neurotransmitter changes in vulnerable brain regions of patients with subjective cognitive decline detected using proton magnetic resonance spectroscopy.Medicine (Baltimore). 2025 Feb 21;104(8):e41474. doi: 10.1097/MD.0000000000041474. Medicine (Baltimore). 2025. PMID: 39993128 Free PMC article.
-
The Role of Machine Learning in Cognitive Impairment in Parkinson Disease: Systematic Review and Meta-Analysis.J Med Internet Res. 2025 Mar 14;27:e59649. doi: 10.2196/59649. J Med Internet Res. 2025. PMID: 40153789 Free PMC article.
-
The identification of cognitive impairment in Parkinson's disease using biofluids, neuroimaging, and artificial intelligence.Front Neurosci. 2024 Sep 26;18:1446878. doi: 10.3389/fnins.2024.1446878. eCollection 2024. Front Neurosci. 2024. PMID: 39403068 Free PMC article.
-
Machine learning for the detection and diagnosis of cognitive impairment in Parkinson's Disease: A systematic review.PLoS One. 2024 May 16;19(5):e0303644. doi: 10.1371/journal.pone.0303644. eCollection 2024. PLoS One. 2024. PMID: 38753740 Free PMC article.
-
A crazy trio in Parkinson's disease: metabolism alteration, α-synuclein aggregation, and oxidative stress.Mol Cell Biochem. 2025 Jan;480(1):139-157. doi: 10.1007/s11010-024-04985-3. Epub 2024 Apr 16. Mol Cell Biochem. 2025. PMID: 38625515 Review.
References
-
- Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68:384–386 - PubMed
-
- Angel RW, Alston W, Higgins JR (1970) Control of movement in Parkinson’s disease. Brain 93:1–14 - PubMed
-
- Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18:509 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical